TRIM25 inhibits influenza A virus infection, destabilizes viral mRNA, but is redundant for activating the RIG-I pathway

Abstract The E3 ubiquitin ligase TRIM25 is a key factor in the innate immune response to RNA viruses. TRIM25 has been shown to play a role in the retinoic-acid-inducible gene-1 (RIG-I) pathway, which triggers expression of type 1 interferons upon viral infection. We and others have shown that TRIM25 is an RNA-binding protein; however, the role of TRIM25 RNA-binding in the innate immune response to RNA viruses is unclear. Here, we demonstrate that influenza A virus (IAV A/PR/8/34_NS1(R38A/K41A)) infection is inhibited by TRIM25. Surprisingly, previously identified RNA-binding deficient mutant TRIM25ΔRBD and E3 ubiquitin ligase mutant TRIM25ΔRING, which lack E3 ubiquitin ligase activity, still inhibited IAV replication. Furthermore, we show that in human-derived cultured cells, activation of the RIG-I/interferon type 1 pathway mediated by either an IAV-derived 5′-triphosphate RNA or by IAV itself does not require TRIM25 activity. Additionally, we present new evidence that instead of TRIM25 directly inhibiting IAV transcription it binds and destabilizes IAV mRNAs. Finally, we show that direct tethering of TRIM25 to RNA is sufficient to downregulate the targeted RNA. In summary, our results uncover a potential mechanism that TRIM25 uses to inhibit IAV infection and regulate RNA metabolism.

[1]  P. Digard,et al.  Compositional biases in RNA viruses: Causes, consequences and applications , 2021, Wiley interdisciplinary reviews. RNA.

[2]  S. Neil,et al.  Targeted Restriction of Viral Gene Expression and Replication by the ZAP Antiviral System. , 2021, Annual review of virology.

[3]  Elizabeth J. Fay,et al.  Segment-Specific Kinetics of mRNA, cRNA, and vRNA Accumulation during Influenza Virus Infection , 2021, Journal of Virology.

[4]  G. Michlewski,et al.  TRIM25 and its emerging RNA‐binding roles in antiviral defense , 2020, Wiley interdisciplinary reviews. RNA.

[5]  Laura F. Dagley,et al.  RIPLET, and not TRIM25, is required for endogenous RIG‐I‐dependent antiviral responses , 2019, Immunology and cell biology.

[6]  Luis Carrasco,et al.  System-wide Profiling of RNA-Binding Proteins Uncovers Key Regulators of Virus Infection , 2019, Molecular cell.

[7]  Jessica J. Chiang,et al.  TRIM25 Binds RNA to Modulate Cellular Anti-viral Defense. , 2018, Journal of molecular biology.

[8]  Michiel van Gent,et al.  TRIM Proteins and Their Roles in Antiviral Host Defenses. , 2018, Annual review of virology.

[9]  M. Binder,et al.  Ubiquitin-Dependent and -Independent Roles of E3 Ligase RIPLET in Innate Immunity , 2019, Cell.

[10]  S. Cusack,et al.  Molecular mechanism of influenza A NS1-mediated TRIM25 recognition and inhibition , 2018, Nature Communications.

[11]  J. Bresee,et al.  Advances in measuring influenza burden of disease , 2018, Influenza and other respiratory viruses.

[12]  R. Krug,et al.  Nuclear TRIM25 Specifically Targets Influenza Virus Ribonucleoproteins to Block the Onset of RNA Chain Elongation. , 2017, Cell host & microbe.

[13]  Juri Rappsilber,et al.  RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination , 2017, bioRxiv.

[14]  P. Bieniasz,et al.  CG-dinucleotide suppression enables antiviral defense targeting non-self RNA , 2017, Nature.

[15]  M. Amorim,et al.  Influenza A Virus NS1 Protein Promotes Efficient Nuclear Export of Unspliced Viral M1 mRNA , 2017, Journal of Virology.

[16]  Fan Tu,et al.  TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein , 2017, Journal of Virology.

[17]  Eugen C. Buehler,et al.  TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP) , 2017, PLoS pathogens.

[18]  P. Lemey,et al.  Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis , 2016, Antimicrobial Agents and Chemotherapy.

[19]  B. Sankaran,et al.  Mechanism of TRIM25 Catalytic Activation in the Antiviral RIG-I Pathway , 2016, Cell reports.

[20]  D. Gubler,et al.  Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness , 2015, Science.

[21]  Yan Zhou,et al.  Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and Interferon Induction , 2015, Journal of Virology.

[22]  J. Rappsilber,et al.  Trim25 Is an RNA-Specific Activator of Lin28a/TuT4-Mediated Uridylation , 2014, Cell reports.

[23]  A. García-Sastre,et al.  TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. , 2014, Journal of molecular biology.

[24]  D. Smee,et al.  Favipiravir (T-705), a novel viral RNA polymerase inhibitor. , 2013, Antiviral research.

[25]  Jeroen Krijgsveld,et al.  The RNA-binding protein repertoire of embryonic stem cells , 2013, Nature Structural &Molecular Biology.

[26]  Adolfo García-Sastre,et al.  The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. , 2013, Immunity.

[27]  R. Albrecht,et al.  Species-Specific Inhibition of RIG-I Ubiquitination and IFN Induction by the Influenza A Virus NS1 Protein , 2012, PLoS pathogens.

[28]  Norman E. Davey,et al.  Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins , 2012, Cell.

[29]  A. Vazquez,et al.  MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors , 2012, BMC Biology.

[30]  C. Basler,et al.  Molecular mechanisms of viral inhibitors of RIG-I-like receptors. , 2012, Trends in microbiology.

[31]  S. Cusack,et al.  Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA , 2011, Cell.

[32]  G. Kochs,et al.  The Viral Nucleoprotein Determines Mx Sensitivity of Influenza A Viruses , 2011, Journal of Virology.

[33]  Kazuhiro Iwai,et al.  Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. , 2011, Molecular cell.

[34]  R. Krug,et al.  Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription. , 2010, Virology.

[35]  Zhijian J. Chen,et al.  Reconstitution of the RIG-I Pathway Reveals a Signaling Role of Unanchored Polyubiquitin Chains in Innate Immunity , 2010, Cell.

[36]  A. Schmidt,et al.  5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I , 2009, Proceedings of the National Academy of Sciences.

[37]  Osamu Takeuchi,et al.  Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. , 2009, Immunity.

[38]  S. Inoue,et al.  Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. , 2009, Cell host & microbe.

[39]  Osamu Takeuchi,et al.  Innate immunity to virus infection , 2009, Immunological reviews.

[40]  Osamu Takeuchi,et al.  TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity , 2007, Nature.

[41]  G. Kochs,et al.  Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein , 2007, Journal of Virology.

[42]  Stefan Hippenstiel,et al.  IFNβ induction by influenza A virus is mediated by RIG‐I which is regulated by the viral NS1 protein , 2007, Cellular microbiology.

[43]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.

[44]  A. Osterhaus,et al.  Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. , 2004, Virus research.

[45]  A. García-Sastre,et al.  A Recombinant Influenza A Virus Expressing anRNA-Binding-Defective NS1 Protein Induces High Levels of BetaInterferon and Is Attenuated inMice , 2003, Journal of Virology.

[46]  C. Samuel,et al.  Antiviral Actions of Interferons , 2001, Clinical Microbiology Reviews.

[47]  A. García-Sastre,et al.  Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein , 2000, Journal of Virology.

[48]  G. Montelione,et al.  RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. , 1999, RNA.

[49]  N. Mcferran,et al.  Dinucleotide and stop codon frequencies in single-stranded RNA viruses. , 1997, The Journal of general virology.

[50]  T. Schlake,et al.  Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. , 1994, Biochemistry.

[51]  S Karlin,et al.  Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? , 1994, Journal of virology.

[52]  E. Yángüez,et al.  Propagation and Titration of Influenza Viruses. , 2018, Methods in molecular biology.